Community-acquired pneumonia
remains the leading cause of hospitalisation for infectious disease in Europe,
and a major cause of morbidity and mortality. This issue of the European
Respiratory Monograph brings together leading experts in pulmonology,
infectious diseases and critical care from around the world to present the most
recent advances in the management of community-acquired pneumonia. It provides
a comprehensive overview of the disease, including chapters on microbiology,
pathophysiology, antibiotic therapy and prevention, along with hot topics such
as viral pneumonias and pneumonia associated with inhaled corticosteroids.